Seres Therapeutics Inc
SWB:1S9
Seres Therapeutics Inc
SWB:1S9
Price:
6.432
EUR
Market Closed
Market Cap:
€4.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Seres Therapeutics Inc
SWB:1S9
|
US |
|
Singapore Telecommunications Ltd
SGX:Z74
|
SG |
|
Nippon Pallet Pool Co Ltd
TSE:4690
|
JP |
|
Thesis Gold Inc
XTSX:TAU
|
CA |
|
Vigil Neuroscience Inc
NASDAQ:VIGL
|
US |
|
G
|
Goodman Property Trust
NZX:GMT
|
NZ |
|
NH Foods Ltd
TSE:2282
|
JP |
|
Parkland Corp
TSX:PKI
|
CA |
|
Japan Securities Finance Co Ltd
TSE:8511
|
JP |
|
K
|
Konica Minolta Inc
OTC:KNCAY
|
JP |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
A
|
Atento SA
OTC:ATTOF
|
LU |
|
A
|
American Airlines Group Inc
XETRA:A1G
|
US |
Wall Street
Price Targets
1S9 Price Targets Summary
Seres Therapeutics Inc
Seres Therapeutics Inc
Wall Street analysts forecast 1S9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
1S9
is 17.348 EUR
with a low forecast of 17.178 EUR and a high forecast of 17.858 EUR.
Lowest
Price Target
17.178
EUR
167% Upside
Average
Price Target
17.348
EUR
170% Upside
Highest
Price Target
17.858
EUR
178% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1S9's stock price target?
Price Target
17.348
EUR
17.348
EUR
According to Wall Street analysts, the average 1-year price target for
1S9
is 17.348 EUR
with a low forecast of 17.178 EUR and a high forecast of 17.858 EUR.
